Company / Named in our posts
Landos Biopharma, Inc..
Follow Landos Biopharma, Inc.A clinical-stage biopharmaceutical company focused on developing novel oral therapeutics for patients with autoimmune diseases.[1]
02Deals
Deals on Carrywatch
Every deal that names Landos Biopharma, Inc., and its role in each.
AbbVie Inc. / Landos Biopharma, Inc.
AbbVie completes acquisition of Landos Biopharma, Inc.
See deal detailsBespin Subsidiary, LLC / Landos Biopharma, Inc.
Landos Biopharma to Become a Subsidiary of Bespin Subsidiary
See deal detailsDeal Web
Landos Biopharma, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
3 fiscal years of figures as Landos Biopharma, Inc. reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Exhibit 99.1: AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02SEC EDGAR company record for Landos Biopharma, Inc.
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Landos Biopharma, Inc.:
- P01
- P02